Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Enanta In-Licenses Chiron's HCV Protease Inhibitor Group

May 20, 2005

By Jennifer Boggs

Enanta In-Licenses Chiron's HCV Protease Inhibitor Group

May 20, 2005

By Jennifer Boggs

Zelos' Series B Round Nets $42M For PTH Drug Pipeline

May 19, 2005

By Jennifer Boggs

Zelos Therapeutics Inc. raised $42.5 million in a Series B round to fund clinical trials of its next-generation parathyroid hormone (PTH) analogue in four indications. (BioWorld Today)

Zelos' Series B Round Nets $42M For PTH Drug Pipeline

May 19, 2005

By Jennifer Boggs

Zelos Therapeutics Inc. raised $42.5 million in a Series B round to fund clinical trials of its next-generation parathyroid hormone (PTH) analogue in four indications. (BioWorld Today)

Licensing Deal Gives Spectrum Radiation Adjunct For Cancer

May 18, 2005

By Jennifer Boggs

Licensing Deal Gives Spectrum Radiation Adjunct For Cancer

May 18, 2005

By Jennifer Boggs

Reverse Merger Gives Rexahn Listing On OTC Bulletin Board

May 17, 2005

By Jennifer Boggs

Xcyte Calls Off Cancer Trial, Shifts Focus To HIV Program

May 17, 2005

By Jennifer Boggs

Xcyte Calls Off Cancer Trial, Shifts Focus To HIV Program

May 17, 2005

By Jennifer Boggs

Reverse Merger Gives Rexahn Listing On OTC Bulletin Board

May 17, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for August 12, 2025.
NME Digest: Q2 2025
BioWorld
A quarterly dynamic table featuring new molecular entities (NMEs) revealed for the first time in current literature, at congresses and in company communications...
Bayer secures KRAS G12D inhibitor with $1.3B Kumquat deal
BioWorld
With a packed pipeline of drug candidates targeting multiple markers of cancer, Bayer AG signed on for a new project, this time going after the KRAS pathway with...
KDCA readies mRNA vaccines, tech for COVID-19, future outbreaks
BioWorld
Korea Disease Control and Prevention Agency (KDCA) secured 5.3 million doses of COVID-19 vaccines made by Pfizer Inc./Biontech SE and Moderna Inc., officially...